{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T11:48:31Z","timestamp":1776167311520,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Scientific and Technological Research Project Fund of the Education Department of Jiangxi Province","award":["Project Number GJJ2200989"],"award-info":[{"award-number":["Project Number GJJ2200989"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03989-9","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T15:42:59Z","timestamp":1764171779000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["FSTL1 is a prognostic marker and promotes invasion and metastasis of colon cancer"],"prefix":"10.1007","volume":"16","author":[{"given":"Chao","family":"Zhong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaorui","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuansen","family":"Shu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiushen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu Xiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"issue":"3","key":"3989_CR1","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.cgh.2023.11.040","volume":"22","author":"S Gupta","year":"2024","unstructured":"Gupta S, May FP, Kupfer SS, Murphy CC. Birth cohort colorectal cancer (CRC): implications for research and practice. Clin Gastroenterol Hepatol. 2024;22(3):455-469.e7. https:\/\/doi.org\/10.1016\/j.cgh.2023.11.040.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"3989_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16081530","volume":"16","author":"G Roshandel","year":"2024","unstructured":"Roshandel G, Ghasemi-Kebria F, Malekzadeh R. Colorectal cancer: epidemiology, risk factors, and prevention. Cancers (Basel). 2024;16(8):1530. https:\/\/doi.org\/10.3390\/cancers16081530.","journal-title":"Cancers (Basel)"},{"issue":"3","key":"3989_CR3","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.hoc.2022.02.002","volume":"36","author":"H Hampel","year":"2022","unstructured":"Hampel H, Kalady MF, Pearlman R, Stanich PP. Hereditary colorectal cancer. HematolOncolClin NorthAm. 2022;36(3):429\u201347. https:\/\/doi.org\/10.1016\/j.hoc.2022.02.002.","journal-title":"HematolOncolClin NorthAm"},{"issue":"9\u201310","key":"3989_CR4","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s10354-022-00975-6","volume":"173","author":"C Zhang","year":"2023","unstructured":"Zhang C, Stampfl-Mattersberger M, Ruckser R, Sebesta C. Kolorektales Karzinom [Colorectal cancer]. Wien MedWochenschr. 2023;173(9\u201310):216\u201320. https:\/\/doi.org\/10.1007\/s10354-022-00975-6.","journal-title":"Wien MedWochenschr."},{"issue":"2","key":"3989_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/cells12020258","volume":"12","author":"I Yu","year":"2023","unstructured":"Yu I, Dakwar A, Takabe K. Immunotherapy: recent advances and its future as a neoadjuvant, adjuvant, and primary treatment in colorectal cancer. Cells. 2023;12(2):258. https:\/\/doi.org\/10.3390\/cells12020258.","journal-title":"Cells"},{"issue":"6","key":"3989_CR6","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41575-019-0126-x","volume":"16","author":"K Ganesh","year":"2019","unstructured":"Ganesh K, Stadler ZK, Cercek A, et al. Immunotherapy in colorectal cancer: rationale, challenges and potential. Nat Rev Gastroenterol Hepatol. 2019;16(6):361\u201375. https:\/\/doi.org\/10.1038\/s41575-019-0126-x.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"9","key":"3989_CR7","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1093\/intimm\/10.9.1305","volume":"10","author":"M Tanaka","year":"1998","unstructured":"Tanaka M, Ozaki S, Osakada F, Mori K, Okubo M, Nakao K. Cloning of follistatin-related protein as a novel autoantigen in systemic rheumatic diseases. Int Immunol. 1998;10(9):1305\u201314. https:\/\/doi.org\/10.1093\/intimm\/10.9.1305.","journal-title":"Int Immunol."},{"issue":"12","key":"3989_CR8","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1136\/gutjnl-2021-325150","volume":"71","author":"J Rao","year":"2022","unstructured":"Rao J, Wang H, Ni M, et al. FSTL1 promotes liver fibrosis by reprogramming macrophage function through modulating the intracellular function ofPKM2. Gut. 2022;71(12):2539\u201350. https:\/\/doi.org\/10.1136\/gutjnl-2021-325150.","journal-title":"Gut"},{"issue":"1","key":"3989_CR9","first-page":"13","volume":"39","author":"X Ni","year":"2018","unstructured":"Ni X, Cao X, Wu Y, Wu J. FSTL1 suppresses tumor cell proliferation, invasion and survival in non-small cell lung cancer. Oncol Rep. 2018;39(1):13\u201320.","journal-title":"Oncol Rep"},{"issue":"21","key":"3989_CR10","doi-asserted-by":"publisher","first-page":"5886","DOI":"10.1158\/0008-5472.CAN-17-1411","volume":"77","author":"MC Lau","year":"2017","unstructured":"Lau MC, Ng KY, Wong TL, et al. FSTL1 Promotes Metastasis and Chemoresistance in Esophageal Squamous Cell Carcinoma through NF\u03baB-BMP Signaling Cross-talk. Cancer Res. 2017;77(21):5886\u201399. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-1411.","journal-title":"Cancer Res."},{"issue":"1","key":"3989_CR11","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner M, et al. Gene ontology: Tool for the unification of biology the gene ontology consortium. Nat Genet. 2000;25(1):25\u20139. https:\/\/doi.org\/10.1038\/75556.","journal-title":"Nat. Genet."},{"issue":"1","key":"3989_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: Kyoto encyclopedia of genes and genomes. Nucl Acids Res. 2000;28(1):27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27.","journal-title":"Nucl. Acids Res."},{"key":"3989_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2023.147857","volume":"892","author":"M Housini","year":"2024","unstructured":"Housini M, Dariya B, Ahmed N, et al. Colorectal cancer: genetic alterations, novel biomarkers, current therapeutic strategies and clinical trials. Gene. 2024;892:147857. https:\/\/doi.org\/10.1016\/j.gene.2023.147857.","journal-title":"Gene"},{"issue":"1","key":"3989_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-04856-x","volume":"22","author":"S Hou","year":"2024","unstructured":"Hou S, Zhao Y, Chen J, Lin Y, Qi X. Tumor-associated macrophages in colorectal cancer metastasis: molecular insights and translational perspectives. J Transl Med. 2024;22(1):62. https:\/\/doi.org\/10.1186\/s12967-024-04856-x.","journal-title":"J Transl Med"},{"key":"3989_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.174365","volume":"907","author":"Q Mu","year":"2021","unstructured":"Mu Q, Najafi M. Modulation of the tumor microenvironment (TME) by melatonin. Eur J Pharmacol. 2021;907:174365. https:\/\/doi.org\/10.1016\/j.ejphar.2021.174365.","journal-title":"Eur J Pharmacol"},{"key":"3989_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.117428","volume":"320","author":"L Ou","year":"2024","unstructured":"Ou L, Liu HR, Shi XY, et al. Terminalia chebula Retz. aqueous extract inhibits the Helicobacter pylori-induced inflammatory response by regulating the inflammasome signaling and ER-stress pathway. J Ethnopharmacol. 2024;320:117428. https:\/\/doi.org\/10.1016\/j.jep.2023.117428.","journal-title":"J Ethnopharmacol"},{"issue":"17","key":"3989_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e37046","volume":"10","author":"L Ou","year":"2024","unstructured":"Ou L, Liu H, Peng C, et al. Helicobacter pylori infection facilitates cell migration and potentially impact clinical outcomes in gastric cancer. Heliyon. 2024;10(17):e37046. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e37046.","journal-title":"Heliyon"},{"issue":"8","key":"3989_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24087493","volume":"24","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Sioud M. Tumor-associated macrophage subsets: shaping polarization and targeting. Int J Mol Sci. 2023;24(8):7493.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"3989_CR19","doi-asserted-by":"publisher","first-page":"326","DOI":"10.2174\/1574892817666220119121204","volume":"17","author":"Z Jin","year":"2022","unstructured":"Jin Z, Zhang W, Liu H, et al. Potential therapeutic application of local anesthetics in cancer treatment. Recent Pat Anticancer Drug Discov. 2022;17(4):326\u201342. https:\/\/doi.org\/10.2174\/1574892817666220119121204.","journal-title":"Recent Pat Anticancer Drug Discov"},{"issue":"6","key":"3989_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2025.167844","volume":"1871","author":"H Liu","year":"2025","unstructured":"Liu H, Hamaia SW, Dobson L, et al. The voltage-gated sodium channel \u03b23 subunit modulates C6 glioma cell motility independently of channel activity. Biochimica et Biophysica Acta (BBA). 2025;1871(6):167844. https:\/\/doi.org\/10.1016\/j.bbadis.2025.167844.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"8","key":"3989_CR21","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/s41568-024-00706-6","volume":"24","author":"R Polak","year":"2024","unstructured":"Polak R, Zhang ET, Kuo CJ. Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment. Nat Rev Cancer. 2024;24(8):523\u201339.","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"3989_CR22","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.19852\/j.cnki.jtcm.20220815.005","volume":"42","author":"L Hengrui","year":"2022","unstructured":"Hengrui L. Toxic medicine used in Traditional Chinese Medicine for cancer treatment: are ion channels involved? J Tradit Chin Med. 2022;42(6):1019\u201322. https:\/\/doi.org\/10.19852\/j.cnki.jtcm.20220815.005.","journal-title":"J Tradit Chin Med."},{"issue":"20","key":"3989_CR23","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v31.i20.106443","volume":"31","author":"HR Liu","year":"2025","unstructured":"Liu HR. Harnessing traditional medicine and biomarker-driven approaches to counteract Trichostatin A-induced esophageal cancer progression. World J Gastroenterol. 2025;31(20):106443. https:\/\/doi.org\/10.3748\/wjg.v31.i20.106443.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"3989_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01827-6","volume":"22","author":"A Glaviano","year":"2023","unstructured":"Glaviano A, Foo ASC, Lam HY, et al. PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer. MolCancer. 2023;22(1):138. https:\/\/doi.org\/10.1186\/s12943-023-01827-6.","journal-title":"MolCancer"},{"issue":"1","key":"3989_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23010573","volume":"23","author":"K Balon","year":"2022","unstructured":"Balon K, Sheriff A, Jack\u00f3w J, \u0141aczma\u0144ski \u0141. Targeting cancer with CRISPR\/Cas9-based therapy. Int J Mol Sci. 2022;23(1):573. https:\/\/doi.org\/10.3390\/ijms23010573.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"3989_CR26","doi-asserted-by":"publisher","first-page":"84","DOI":"10.15212\/bioi-2022-0008","volume":"4","author":"Shimei Li","year":"2023","unstructured":"Li Shimei, Yao Jiyi, Zhang Shen, et al. Prognostic value of tumor-microenvironment-associated genes in ovarian cancer. BIOI. 2023;4(3):84\u201396. https:\/\/doi.org\/10.15212\/bioi-2022-0008.","journal-title":"BIOI"},{"issue":"1","key":"3989_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01441-4","volume":"20","author":"G Zhu","year":"2021","unstructured":"Zhu G, Pei L, Xia H, Tang Q, Bi F. Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer. MolCancer. 2021;20(1):143. https:\/\/doi.org\/10.1186\/s12943-021-01441-4.","journal-title":"MolCancer"},{"key":"3989_CR28","doi-asserted-by":"publisher","unstructured":"Liebl MC, Hofmann TG. The Role ofp53 Signaling in Colorectal Cancer. Cancers(Basel). 2021;13(9):2125. Published 2021 Apr 28. https:\/\/doi.org\/10.3390\/cancers13092125","DOI":"10.3390\/cancers13092125"},{"issue":"8","key":"3989_CR29","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1038\/s41416-023-02149-6","volume":"128","author":"H Yan","year":"2023","unstructured":"Yan H, Talty R, Aladelokun O, Bosenberg M, Johnson CH. Ferroptosis in colorectal cancer: a future target? Br J Cancer. 2023;128(8):1439\u201351. https:\/\/doi.org\/10.1038\/s41416-023-02149-6.","journal-title":"Br J Cancer"},{"issue":"1","key":"3989_CR30","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-024-01538-2","volume":"25","author":"H Liu","year":"2024","unstructured":"Liu H, Wang P. Crispr screening and cell line IC50 data reveal novel key genes for trametinib resistance. Clin Exp Med. 2024;25(1):21. https:\/\/doi.org\/10.1007\/s10238-024-01538-2.","journal-title":"Clin Exp Med"},{"issue":"11","key":"3989_CR31","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.6004\/jnccn.2016.0154","volume":"14","author":"CD Williams","year":"2016","unstructured":"Williams CD, Grady WM, Zullig LL. Use of NCCN guidelines, other guidelines, and biomarkers for colorectal cancer screening. J Natl Compr Canc Netw. 2016;14(11):1479\u201385. https:\/\/doi.org\/10.6004\/jnccn.2016.0154.","journal-title":"J Natl Compr Canc Netw"},{"key":"3989_CR32","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cancergen.2024.06.002","volume":"286\u2013287","author":"D Sonkin","year":"2024","unstructured":"Sonkin D, Thomas A, Teicher BA. Cancer treatments: past, present, and future. Cancer Genet. 2024;286\u2013287:18\u201324. https:\/\/doi.org\/10.1016\/j.cancergen.2024.06.002.","journal-title":"Cancer Genet"},{"issue":"2","key":"3989_CR33","doi-asserted-by":"publisher","first-page":"289","DOI":"10.21147\/j.issn.1000-9604.2025.02.12","volume":"37","author":"H Liu","year":"2025","unstructured":"Liu H, Dilger JP. Different strategies for cancer treatment: targeting cancer cells or their neighbors? Chin J Cancer Res. 2025;37(2):289\u201392. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2025.02.12.","journal-title":"Chin J Cancer Res"},{"issue":"1","key":"3989_CR34","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.immuni.2022.12.008","volume":"56","author":"J Park","year":"2023","unstructured":"Park J, Hsueh PC, Li Z, Ho PC. Microenvironment-driven metabolic adaptations guiding CD8+ T cell anti-tumor immunity. Immunity. 2023;56(1):32\u201342. https:\/\/doi.org\/10.1016\/j.immuni.2022.12.008.","journal-title":"Immunity"},{"issue":"1","key":"3989_CR35","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3390\/pharmaceutics15010112","volume":"15","author":"R Ali","year":"2022","unstructured":"Ali R, Shao H, Varamini P. Potential nanotechnology-based therapeutics to prevent cancer progression through TME cell-driven populations. Pharmaceutics. 2022;15(1):112. https:\/\/doi.org\/10.3390\/pharmaceutics15010112.","journal-title":"Pharmaceutics."},{"issue":"9","key":"3989_CR36","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.tcb.2020.06.003","volume":"30","author":"M St Paul","year":"2020","unstructured":"St Paul M, Ohashi PS. The roles of CD8+ T cell subsets in antitumor immunity. Trends Cell Biol. 2020;30(9):695\u2013704. https:\/\/doi.org\/10.1016\/j.tcb.2020.06.003.","journal-title":"Trends Cell Biol"},{"issue":"4","key":"3989_CR37","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41568-023-00549-7","volume":"23","author":"M Tsoumakidou","year":"2023","unstructured":"Tsoumakidou M. The advent of immune stimulating CAFs in cancer. Nat Rev Cancer. 2023;23(4):258\u201369. https:\/\/doi.org\/10.1038\/s41568-023-00549-7.","journal-title":"Nat Rev Cancer."},{"issue":"1","key":"3989_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01428-1","volume":"20","author":"X Mao","year":"2021","unstructured":"Mao X, Xu J, Wang W, et al. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives. MolCancer. 2021;20(1):131. https:\/\/doi.org\/10.1186\/s12943-021-01428-1.","journal-title":"MolCancer"},{"issue":"4","key":"3989_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/cells12040628","volume":"12","author":"D Mishra","year":"2023","unstructured":"Mishra D, Banerjee D. Secretome of stromal cancer-associated fibroblasts (CAFs): relevance in cancer. Cells. 2023;12(4):628. https:\/\/doi.org\/10.3390\/cells12040628.","journal-title":"Cells"},{"issue":"18","key":"3989_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13184720","volume":"13","author":"PJ Asif","year":"2021","unstructured":"Asif PJ, Longobardi C, Hahne M, Medema JP. The role of cancer-associated fibroblasts in cancer invasion and metastasis. Cancers(Basel). 2021;13(18):4720. https:\/\/doi.org\/10.3390\/cancers13184720.","journal-title":"Cancers(Basel)"},{"issue":"1","key":"3989_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01731-z","volume":"22","author":"L Pei","year":"2023","unstructured":"Pei L, Liu Y, Liu L, et al. Roles of cancer-associated fibroblasts (CAFs) in anti- PD-1\/PD-L1 immunotherapy for solid cancers. MolCancer. 2023;22(1):29. https:\/\/doi.org\/10.1186\/s12943-023-01731-z.","journal-title":"MolCancer"},{"issue":"6","key":"3989_CR42","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1042\/BCJ20161047","volume":"474","author":"SP Narayanan","year":"2017","unstructured":"Narayanan SP, Singh S, Shukla S. A saga of cancer epigenetics: linking epigenetics to alternative splicing. Biochem J. 2017;474(6):885\u201396. https:\/\/doi.org\/10.1042\/BCJ20161047.","journal-title":"Biochem J"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03989-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03989-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03989-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T15:43:00Z","timestamp":1764171780000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03989-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3989"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03989-9","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"assertion":[{"value":"14 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2173"}}